Kovai Medical Q1 FY27: standalone PAT +21% YoY to ₹69 Cr as margins expand

Kovai Medical Center & Hospital's standalone revenue from operations rose 15.3% YoY (4.3% QoQ) to ₹431.31 Cr in Q1 FY27, while standalone net profit grew faster at 20.7% YoY (15.8% QoQ) to ₹69.09 Cr — profit outpacing revenue with no exceptional items on either side, a clean strong quarter rather than an accounting-driven one. EPS came in at ₹63.14 versus ₹52.30 a year ago and ₹57.90 last quarter. The margin expansion (OPM 28.7% vs 28.3% YoY and 26.8% QoQ; NPM 15.7% vs 15.1% YoY and 14.1% QoQ) was driven almost entirely by the Healthcare segment, whose segment PBIT rose 22.9% YoY to ₹93.87 Cr; the Education segment moved the other way, with PBIT down 30.9% YoY to ₹10.94 Cr from ₹15.83 Cr, partly offsetting the Healthcare gains at the consolidated-segment level. Finance costs fell to ₹8.02 Cr from ₹9.17 Cr a year ago even as total capital employed rose to ₹1,388.26 Cr from ₹1,143.36 Cr, suggesting the incremental capital deployed has not yet added proportionate debt-servicing cost. There is no consensus/street estimate on record for this print — KMCH is a thinly-covered small-cap and a web search turned up no Q1 FY27 preview or brokerage estimate, so vsStreet is unknown rather than a miss. Similarly, management has issued no formal forward guidance in our records or in this filing, so the quarter cannot be graded against a prior outlook. The board outcome letter accompanying this filing carries no separate management commentary on the numbers beyond the statutory disclosures — alongside the results, the board also approved a postal ballot to re-designate Dr. Arun N Palaniswami as Joint Managing Director (e-voting cut-off 14 August 2026), a governance item unconnected to this quarter's financial performance. This is also the first result since the company corrected a tax-expense error in the previously reported Q4 FY26 numbers (May 2026); this quarter's tax line (₹22.45 Cr, effective rate ~24.5% of PBT) shows no similar anomaly. Going into Q2 FY27, the print sets up a healthcare-segment-led growth story with the Education segment as the drag to watch.